Q1 2026 Management View Michael Farrell, CEO & Chairman, highlighted a strong quarter, reporting "9% reported revenue growth or 8% on a constant currency basis, with multiple areas of high performance ...
ResMed (NYSE:RMD) said it is updating the guides for all of its masks with magnets to alert users to potential magnetic interference with certain medical devices and implants. ResMed said that the ...
Please provide your email address to receive an email when new articles are posted on . ResMed CPAP masks that contain magnets are being recalled due to possible magnetic interference with medical ...
Resmed Inc (($RMD)) has held its Q1 earnings call. Read on for the main highlights of the call. ResMed Inc. recently held its earnings call for ...
ResMed’s voluntary recall of some of its CPAP mask magnets has now been labeled as Class I by FDA. The agency announced the classification late last week. In November, ResMed began recalling some ...
We maintain our USD 258 fair value estimate for narrow-moat ResMed RMD, or AUD 40 per CDI at current exchange rates, following first-quarter fiscal 2024 results. Underlying EBIT of USD 319 million ...